Please provide your email address to receive an email when new articles are posted on . Dermatologists should avoid the removal of benign nevi from children that are not of a consenting age, ...

The dysplastic nevus initially was described in the 1980s as a mole with increased risk of developing melanoma and requiring total removal. However, dermatopathologists now consider dysplastic nevi to ...

An intradermal nevus (also called an intradermal melanocytic nevus) is simply a classic mole or birthmark. It typically appears as an elevated, dome-shaped bump on the surface of the skin. It’s ...

Philadelphia, September 30, 2019 - Melanoma is the least common but one of the most deadly skin cancers. It accounts for only about one percent of all cases globally, but the majority of skin cancer ...

The use of lasers to treat melanocytic nevi had been subject to debate because of concerns about malignant transformation. In the last few years, it has become relatively clear that such treatment is ...

Melanoma is rare in children. However, the clinical features of the disease in this population have been well-documented through single-institution experiences and population-based analyses. Still, ...

A mole removal scar typically fades over time. However, there are ways to reduce the appearance more quickly. Moles, or nevi, are so common that most adults have at least a few. While some moles can ...

The first description of a particular melanocytic nevus found in relatives from six cases of melanoma was made in 1978. [1] Although initially coined B-K moles, these moles soon acquired the name ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

For as long as I can remember, I've had a weird blue mole on my right hand. And for almost as long, I've been anxious that it's not just a blue mole, but maybe, idk, cancer? But, thankfully no.

About a third of melanomas begin with benign moles. Now, researchers at Massachusetts General Hospital have found an immune mechanism for these noncancerous skin cells that they believe could be ...